Ajanta Pharma gets USFDA nod for Fluphenazine Hydrochloride tablet

Ajanta Pharma gets USFDA nod for Fluphenazine Hydrochloride tablet

The drug is used to treat psychotic disorders such as schizophrenia

FPJ Web DeskUpdated: Tuesday, January 10, 2023, 04:01 PM IST
article-image
Ajanta Pharma gets USFDA nod for Fluphenazine Hydrochloride tablet | Image: Ajanta Pharma (Representative)

Ajanta Pharma Ltd has received an approval from the US Food and Drug Administration (USFDA) for Fluphenazine Hydrochloride tablet, as per an exchange filing.

The dosage is in 1 mg, 2.5 mg, 5 mg and 10 mg strengths, according to an update on the drug regulator's website.

The drug is used to treat psychotic disorders such as schizophrenia.

RECENT STORIES

Blinkit-Airtel SIM Home Delivery Halts, DoT Says " Norms Have To Be Complied With"

Blinkit-Airtel SIM Home Delivery Halts, 
DoT Says

SEBI Turnover Fees Update, GST To Apply Across All Segments

SEBI Turnover Fees Update, GST To Apply Across All Segments

Over 12,000 Property Registrations Recorded In April; Reflects Interest In Premium Housing

Over 12,000 Property Registrations Recorded In April; Reflects Interest In Premium Housing

Maharashtra Sugar Quota Cut For May, Uttar Pradesh Gets Boost

Maharashtra Sugar Quota Cut For May, Uttar Pradesh Gets Boost

SEBI Alerts Public: 'Opinion Trading Platforms' Defy Regulations

SEBI Alerts Public: 'Opinion Trading Platforms' Defy Regulations